Authentikos Wealth Advisory’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-70
Closed -$112 638
2023
Q3
$112 Buy
+70
New +$193 ﹤0.01% 630

Other funds holding RNLX

Authentikos Wealth Advisory's RNLX Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2023, closing a stake of 70 shares — an estimated $112 sold.

Authentikos Wealth Advisory first reported a position in RNLX in Q3 2023 and held it in 1 quarter. The position peaked at $112 in Q3 2023. 27 funds tracked by Wall St. Rank hold RNLX as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining Renalytix plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 70 Renalytix plc American Depositary Shares shares in Q4 2023, an estimated $112.
  • Authentikos Wealth Advisory first reported a position in Renalytix plc American Depositary Shares in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's Renalytix plc American Depositary Shares position peaked at $112 in Q3 2023.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.